Inactive Instrument

RIGHTSMIL Stock Other OTC

US76657X1037

Biotechnology & Medical Research

End-of-day quote Other OTC
- ^USD	-

30/03/16	Bud Genius, Inc. cancelled the acquisition of Evergreen Licensing.	CI
09/04/15	Bud Genius, Inc.'s Board intends to launch an Equity Buyback.	CI

Rightsmile, Inc provides medical marijuana testing and medicine matching services. The Company works with dispensary, growers, product manufacturers and patients. It accepts selections from customersâ€™ strain inventory and returns them the reporting package in the industry. All of its testing results are stored online. The Company provides three forms of strain identification markers, which include BudGenius StrainId Card, BudGenius StrainId Online Badge and BudGenius StrainId Certified Labels. The BudGenius StrainId Card is an identification card that ensures to patients that their test results are not modified through Photoshop trickery. The Company offers two types of reports for medical marijuana testing and strain information, which include BudGenius Scientific Analysis Online Report and BudGenius Scientific Analysis Written Report.

Employees

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	317 271.67 254.15 232.35 438.47 30.35K 443.13 3.01K 1.17K 15.24K 1.19K 1.16K 50.43K	P/E 2009	-23.5x	P/E 2010	-
Enterprise Value	396K 340K 318K 291K 548K 37.96M 554K 3.76M 1.46M 19.06M 1.49M 1.46M 63.07M	EV / Sales 2009	-	EV / Sales 2010	9,639,795x
Free-Float	100%	Yield 2009 *	-	Yield 2010	-

30/03/16	Bud Genius, Inc. cancelled the acquisition of Evergreen Licensing.	CI
09/04/15	Bud Genius, Inc.'s Board intends to launch an Equity Buyback.	CI
02/04/15	Bud Genius, Inc. Appoints Peter Wilson, Ph.D. to its Advisory Board	CI
30/03/15	Bud Genius Announces LOI to Acquire Evergreen Licensing	CI
30/03/15	Bud Genius, Inc. enter into a letter of intent to acquire Evergreen Licensing.	CI
16/03/15	Bud Genius, Inc. Adds Randall A. Huft to the Executive Team	CI
18/09/14	Tranche Update on Bud Genius, Inc.'s Equity Buyback Plan announced on September 4, 2014.	CI
18/09/14	Bud Genius, Inc.’s Equity Buyback announced on September 4, 2014 has closed.	CI
04/09/14	Bud Genius, Inc. announces an Equity Buyback for 1,499,000,000 shares, representing 5% of its issued share capital.	CI
04/09/14	Bud Genius, Inc. authorizes a Buyback Plan.	CI
13/08/14	RightSmile, Inc. has Changed its Name to Bud Genius, Inc	CI
29/03/12	BG Medical Technologies, Inc. Announces New Medical Marijuana Division	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.21%	+5.02%	+3.74%	+25.54%	51.21B
REVOLUTION MEDICINES, INC.	+1.01%	-0.20%	+471.68%	+564.93%	45.35B
IQVIA HOLDINGS INC.	+0.16%	+7.88%	+36.14%	+20.76%	42.84B
BEONE MEDICINES AG	-0.66%	+2.61%	+18.59%	+87.04%	42.29B
CELLTRION, INC.	+0.88%	-3.48%	+17.20%	+53.83%	32.15B
MEDPACE HOLDINGS, INC.	-0.12%	+3.84%	+33.73%	+145.25%	17.31B
ASCENDIS PHARMA A/S	-0.53%	+1.84%	-	-	16.55B
EUROFINS SCIENTIFIC SE	+0.66%	+5.86%	+10.49%	+32.01%	14.84B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.15%	+4.17%	+84.49%	+50.33%	14.25B
Average	+0.42%	+3.23%	+84.51%	+122.46%	30.75B
Weighted average by Cap.	+0.47%	+3.07%	+101.50%	+141.92%

	2009	2010
Net sales	-	0.04 0.04 0.03 0.03 0.06 4.05 0.06 0.4 0.16 2.03 0.16 0.16 6.72
Net income	-21.5K -18.43K -17.24K -15.76K -29.75K -2.06M -30.06K -204K -79.33K -1.03M -80.74K -79K -3.42M	-851K -729K -682K -624K -1.18M -81.47M -1.19M -8.07M -3.14M -40.91M -3.19M -3.13M -135M
Net Debt	489K 419K 392K 359K 677K 46.84M 684K 4.64M 1.8M 23.52M 1.84M 1.8M 77.82M	396K 339K 318K 290K 548K 37.93M 554K 3.76M 1.46M 19.05M 1.49M 1.46M 63.02M

RIGHTSMIL Stock Other OTC

Stocks

US76657X1037

Biotechnology & Medical Research

Valuation: RIGHTSMIL

Latest news : RIGHTSMIL

Other Biotechnology & Medical Research

Financials

Company Profile